众生药业
(002317)
| 流通市值：191.16亿 | | | 总市值：211.55亿 |
| 流通股本：7.68亿 | | | 总股本：8.50亿 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 1,468,004,093.45 | 1,000,420,115.22 | 624,239,320.67 | 2,522,737,619.7 |
| 营业总成本 | 1,334,467,479.62 | 888,603,999.58 | 514,225,795.98 | 2,225,746,035.9 |
| 其他经营收益 | | | | |
| 营业利润 | 199,240,882.96 | 119,313,529.36 | 112,190,162.14 | 298,299,493.92 |
| 利润总额 | 202,644,301.65 | 123,598,450.96 | 117,692,336.37 | 296,585,833.52 |
| 净利润 | 179,194,428.12 | 106,746,970.3 | 98,025,231.34 | 266,704,568.89 |
| 每股收益 | | | | |
| 其他综合收益 | -2,534,105.87 | -810,552.41 | -465,901.91 | -5,349,740.05 |
| 综合收益总额 | 176,660,322.25 | 105,936,417.89 | 97,559,329.43 | 261,354,828.84 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 3,153,158,935.6 | 3,021,095,580.31 | 3,430,641,844.35 | 3,043,657,559.41 |
| 非流动资产: | | | | |
| 非流动资产合计 | 1,975,434,698.44 | 1,946,316,184.16 | 1,911,178,346.69 | 2,085,889,813.67 |
| 资产总计 | 5,128,593,634.04 | 4,967,411,764.47 | 5,341,820,191.04 | 5,129,547,373.08 |
| 流动负债: | | | | |
| 流动负债合计 | 724,745,625.34 | 621,645,697.49 | 829,584,469.9 | 718,319,427.71 |
| 非流动负债: | | | | |
| 非流动负债合计 | 237,322,406.58 | 254,671,277.42 | 262,239,384.39 | 261,386,177.8 |
| 负债合计 | 962,068,031.92 | 876,316,974.91 | 1,091,823,854.29 | 979,705,605.51 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 4,072,324,891.55 | 4,004,184,524.29 | 4,160,206,822.87 | 4,058,166,288.88 |
| 股东权益合计 | 4,166,525,602.12 | 4,091,094,789.56 | 4,249,996,336.75 | 4,149,841,767.57 |
| 负债和股东权益合计 | 5,128,593,634.04 | 4,967,411,764.47 | 5,341,820,191.04 | 5,129,547,373.08 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 2,052,426,226.91 | 1,494,245,241.64 | 672,674,121.41 | 2,362,757,029.65 |
| 经营活动现金流出小计 | 1,418,494,224.06 | 952,491,909.37 | 531,139,427.04 | 2,057,552,446.97 |
| 经营活动产生的现金流量净额 | 633,932,002.85 | 541,753,332.27 | 141,534,694.37 | 305,204,582.68 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 749,513,093.95 | 502,623,282.47 | 133,042,420.55 | 1,307,334,963.47 |
| 投资活动现金流出小计 | 1,269,687,518.87 | 920,100,144.38 | 488,410,357.59 | 1,261,170,977.1 |
| 投资活动产生的现金流量净额 | -520,174,424.92 | -417,476,861.91 | -355,367,937.04 | 46,163,986.37 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 143,087,116.3 | 21,887,979.43 | 18,791,591 | 398,206,741.24 |
| 筹资活动现金流出小计 | 384,241,894.17 | 383,909,356.43 | 50,619,886.95 | 1,133,736,011.74 |
| 筹资活动产生的现金流量净额 | -241,154,777.87 | -362,021,377 | -31,828,295.95 | -735,529,270.5 |
| 汇率变动对现金及现金等价物的影响 | -56,001.21 | -41,578.85 | -20,914.64 | -30,491.28 |
| 现金及现金等价物净增加额 | -127,453,201.15 | -237,786,485.49 | -245,682,453.26 | -384,191,192.73 |
| 期末现金及现金等价物余额 | 850,440,168.12 | 740,106,883.78 | 732,210,916.01 | 977,893,369.27 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | -237,786,485.49 | - | -384,191,192.73 |
最新报告期：2026-09-08| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 东海证券 | 杜永宏 | 0.41 | 0.47 | 0.56 | 2026-09-08 |
| 国投证券 | 冯俊曦,连国强 | 0.27 | 0.38 | 0.50 | 2026-09-02 |
| 开源证券 | 余汝意,巢舒然 | 0.25 | 0.35 | 0.40 | 2026-08-27 |